Semler Total Assets vs Capital Surpluse Analysis

SMLR Stock

USD 57.02 4.03 6.60%

Semler Scientific financial indicator trend analysis is much more than just breaking down Semler Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Semler Scientific is a good investment. Please check the relationship between Semler Scientific Total Assets and its Capital Surpluse accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Semler Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Semler Stock, please use our How to Invest in Semler Scientific guide.

Total Assets vs Capital Surpluse

Total Assets vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Semler Scientific Total Assets account and Capital Surpluse. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Semler Scientific's Total Assets and Capital Surpluse is -0.39. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Semler Scientific, assuming nothing else is changed. The correlation between historical values of Semler Scientific's Total Assets and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Semler Scientific are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Total Assets i.e., Semler Scientific's Total Assets and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

-0.39

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Total Assets

Total assets refers to the total amount of Semler Scientific assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Semler Scientific books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Capital Surpluse

Most indicators from Semler Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Semler Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Semler Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Semler Stock, please use our How to Invest in Semler Scientific guide.At this time, Semler Scientific's Selling General Administrative is relatively stable compared to the past year. As of 11/29/2024, Tax Provision is likely to grow to about 5.9 M, while Sales General And Administrative To Revenue is likely to drop 0.20.

	2021	2022	2023	2024 (projected)
Interest Expense	638K	489K	562.4K	359.7K
Depreciation And Amortization	628K	589K	599K	335.5K

Interest Expense Depreciation And Amortization

Semler Scientific fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Assets	Long Term Debt	Preferred Stock Total Equity
Total Assets		-0.46	0.41	0.67	1.0	0.75	0.68	-0.97	0.96	0.41	0.96	0.94	0.46	1.0	0.93	0.67	-0.36	0.45	0.16	0.51	1.0	-0.17	0.63	0.37	-0.49	0.41
Short Long Term Debt Total	-0.46		0.09	0.07	-0.49	-0.21	-0.02	0.47	-0.6	0.21	-0.44	-0.46	-0.33	-0.46	-0.41	-0.29	0.31	-0.19	0.43	0.24	-0.46	-0.02	0.02	-0.38	0.7	0.2
Other Current Liab	0.41	0.09		0.83	0.37	0.78	0.75	-0.32	0.17	0.57	0.32	0.52	0.11	0.35	0.65	0.82	-0.23	0.8	0.75	0.72	0.38	0.42	0.86	0.41	-0.29	0.72
Total Current Liabilities	0.67	0.07	0.83		0.64	0.9	0.93	-0.57	0.46	0.68	0.56	0.72	0.37	0.64	0.73	0.83	-0.34	0.65	0.65	0.81	0.65	0.23	0.94	0.49	-0.25	0.81
Total Stockholder Equity	1.0	-0.49	0.37	0.64		0.73	0.66	-0.97	0.97	0.39	0.97	0.93	0.45	1.0	0.92	0.65	-0.39	0.43	0.12	0.47	1.0	-0.18	0.61	0.36	-0.5	0.39
Property Plant And Equipment Net	0.75	-0.21	0.78	0.9	0.73		0.91	-0.66	0.58	0.7	0.63	0.85	0.45	0.71	0.81	0.91	-0.32	0.66	0.51	0.73	0.72	0.2	0.9	0.63	-0.41	0.7
Current Deferred Revenue	0.68	-0.02	0.75	0.93	0.66	0.91		-0.6	0.49	0.76	0.58	0.74	0.33	0.64	0.72	0.84	-0.44	0.63	0.59	0.68	0.65	0.18	0.91	0.57	-0.16	0.81
Net Debt	-0.97	0.47	-0.32	-0.57	-0.97	-0.66	-0.6		-0.94	-0.28	-1.0	-0.84	-0.24	-0.97	-0.91	-0.61	0.35	-0.45	-0.11	-0.41	-0.98	0.18	-0.58	-0.26	0.46	-0.39
Retained Earnings	0.96	-0.6	0.17	0.46	0.97	0.58	0.49	-0.94		0.23	0.94	0.88	0.47	0.96	0.83	0.47	-0.33	0.26	-0.13	0.32	0.96	-0.32	0.4	0.28	-0.5	0.19
Accounts Payable	0.41	0.21	0.57	0.68	0.39	0.7	0.76	-0.28	0.23		0.27	0.53	0.45	0.37	0.43	0.58	-0.22	0.33	0.58	0.56	0.38	-0.04	0.62	0.45	-0.04	0.55
Cash	0.96	-0.44	0.32	0.56	0.97	0.63	0.58	-1.0	0.94	0.27		0.84	0.22	0.97	0.91	0.59	-0.34	0.43	0.13	0.42	0.97	-0.18	0.57	0.23	-0.45	0.38
Non Current Assets Total	0.94	-0.46	0.52	0.72	0.93	0.85	0.74	-0.84	0.88	0.53	0.84		0.59	0.91	0.89	0.71	-0.35	0.41	0.18	0.56	0.91	-0.03	0.66	0.49	-0.51	0.41
Non Currrent Assets Other	0.46	-0.33	0.11	0.37	0.45	0.45	0.33	-0.24	0.47	0.45	0.22	0.59		0.44	0.26	0.27	-0.14	-0.05	-0.12	0.29	0.42	-0.26	0.17	0.5	-0.28	0.01
Cash And Short Term Investments	1.0	-0.46	0.35	0.64	1.0	0.71	0.64	-0.97	0.96	0.37	0.97	0.91	0.44		0.91	0.62	-0.35	0.41	0.12	0.49	1.0	-0.22	0.59	0.32	-0.47	0.39
Net Receivables	0.93	-0.41	0.65	0.73	0.92	0.81	0.72	-0.91	0.83	0.43	0.91	0.89	0.26	0.91		0.8	-0.4	0.66	0.36	0.55	0.92	0.05	0.75	0.33	-0.53	0.53
Common Stock Shares Outstanding	0.67	-0.29	0.82	0.83	0.65	0.91	0.84	-0.61	0.47	0.58	0.59	0.71	0.27	0.62	0.8		-0.43	0.83	0.65	0.59	0.65	0.4	0.92	0.65	-0.51	0.75
Non Current Liabilities Total	-0.36	0.31	-0.23	-0.34	-0.39	-0.32	-0.44	0.35	-0.33	-0.22	-0.34	-0.35	-0.14	-0.35	-0.4	-0.43		-0.35	-0.2	0.26	-0.35	-0.24	-0.39	-0.25	0.23	-0.37
Other Current Assets	0.45	-0.19	0.8	0.65	0.43	0.66	0.63	-0.45	0.26	0.33	0.43	0.41	-0.05	0.41	0.66	0.83	-0.35		0.62	0.45	0.45	0.38	0.77	0.53	-0.41	0.56
Other Stockholder Equity	0.16	0.43	0.75	0.65	0.12	0.51	0.59	-0.11	-0.13	0.58	0.13	0.18	-0.12	0.12	0.36	0.65	-0.2	0.62		0.55	0.15	0.5	0.77	0.24	0.05	0.73
Total Liab	0.51	0.24	0.72	0.81	0.47	0.73	0.68	-0.41	0.32	0.56	0.42	0.56	0.29	0.49	0.55	0.59	0.26	0.45	0.55		0.5	0.06	0.72	0.32	-0.14	0.59
Total Current Assets	1.0	-0.46	0.38	0.65	1.0	0.72	0.65	-0.98	0.96	0.38	0.97	0.91	0.42	1.0	0.92	0.65	-0.35	0.45	0.15	0.5		-0.2	0.62	0.34	-0.48	0.4
Short Term Debt	-0.17	-0.02	0.42	0.23	-0.18	0.2	0.18	0.18	-0.32	-0.04	-0.18	-0.03	-0.26	-0.22	0.05	0.4	-0.24	0.38	0.5	0.06	-0.2		0.38	0.29	-0.17	0.3
Common Stock	0.63	0.02	0.86	0.94	0.61	0.9	0.91	-0.58	0.4	0.62	0.57	0.66	0.17	0.59	0.75	0.92	-0.39	0.77	0.77	0.72	0.62	0.38		0.49	-0.27	0.89
Other Assets	0.37	-0.38	0.41	0.49	0.36	0.63	0.57	-0.26	0.28	0.45	0.23	0.49	0.5	0.32	0.33	0.65	-0.25	0.53	0.24	0.32	0.34	0.29	0.49		-0.43	0.23
Long Term Debt	-0.49	0.7	-0.29	-0.25	-0.5	-0.41	-0.16	0.46	-0.5	-0.04	-0.45	-0.51	-0.28	-0.47	-0.53	-0.51	0.23	-0.41	0.05	-0.14	-0.48	-0.17	-0.27	-0.43		-0.03
Preferred Stock Total Equity	0.41	0.2	0.72	0.81	0.39	0.7	0.81	-0.39	0.19	0.55	0.38	0.41	0.01	0.39	0.53	0.75	-0.37	0.56	0.73	0.59	0.4	0.3	0.89	0.23	-0.03

Click cells to compare fundamentals

Semler Scientific Account Relationship Matchups

Semler Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	18.3M	34.6M	50.7M	62.7M	78.1M	82.0M
Other Current Liab	3.9M	2.0M	2.3M	2.9M	2.6M	2.3M
Total Current Liabilities	5.2M	4.5M	4.9M	6.9M	6.2M	4.4M
Total Stockholder Equity	13.1M	29.8M	45.5M	55.7M	71.8M	75.4M
Property Plant And Equipment Net	2.3M	2.5M	2.0M	3.1M	3.0M	1.7M
Current Deferred Revenue	955K	963K	921K	1.2M	1.1M	729.1K
Net Debt	(7.7M)	(21.7M)	(37.0M)	(22.8M)	(57.0M)	(54.2M)
Retained Earnings	(6.3M)	7.7M	24.9M	39.2M	59.8M	62.8M
Accounts Payable	338K	677K	443K	835K	402K	448.5K
Cash	7.7M	22.1M	37.3M	23.0M	57.2M	60.1M
Non Current Assets Total	6.8M	8.4M	5.1M	13.8M	12.1M	12.7M
Cash And Short Term Investments	7.7M	22.1M	37.3M	43.1M	57.2M	60.1M
Net Receivables	3.5M	2.8M	3.6M	3.9M	6.1M	6.4M
Common Stock Shares Outstanding	8.0M	8.1M	8.1M	8.0M	7.8M	6.6M
Liabilities And Stockholders Equity	18.3M	34.6M	50.7M	62.7M	78.1M	82.0M
Non Current Liabilities Total	7K	332K	245K	160K	70K	66.5K
Other Current Assets	3.7M	1.4M	4.0M	1.5M	2.2M	1.7M
Other Stockholder Equity	19.4M	22.1M	20.6M	16.4M	12.0M	18.6M
Total Liab	5.2M	4.8M	5.1M	7.0M	6.3M	5.2M
Total Current Assets	11.4M	26.3M	45.5M	48.9M	65.9M	69.2M
Other Assets	4.5M	5.1M	5.1M	5.1M	1.0	0.95
Property Plant Equipment	249K	261K	1.6M	2.5M	2.8M	3.0M
Net Tangible Assets	13.1M	29.8M	45.5M	55.7M	64.0M	67.2M
Retained Earnings Total Equity	(6.3M)	7.7M	24.9M	39.2M	45.1M	47.4M
Capital Surpluse	19.4M	22.1M	20.6M	16.4M	14.8M	16.8M
Inventory	(3.5M)	(2.8M)	550K	469K	445K	467.3K
Other Liab	11K	7K	332K	160K	184K	125.1K
Net Invested Capital	13.1M	29.8M	45.5M	55.7M	71.8M	75.4M
Property Plant And Equipment Gross	2.3M	2.5M	4.1M	3.1M	4.9M	3.1M
Net Working Capital	6.2M	21.7M	40.7M	42.1M	59.7M	62.7M

Pair Trading with Semler Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Semler Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Semler Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Semler Stock

0.84	GH	Guardant Health	Pair Corr
0.81	LH	Laboratory	Pair Corr

Moving against Semler Stock

0.89	EKSO	Ekso Bionics Holdings	Pair Corr
0.7	VERO	Venus Concept	Pair Corr
0.53	DRIO	DarioHealth Corp	Pair Corr
0.44	CI	Cigna Corp	Pair Corr

The ability to find closely correlated positions to Semler Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Semler Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Semler Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Semler Scientific to buy it.

The correlation of Semler Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Semler Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Semler Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Semler Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Semler Stock Analysis

When running Semler Scientific's price analysis, check to measure Semler Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Semler Scientific is operating at the current time. Most of Semler Scientific's value examination focuses on studying past and present price action to predict the probability of Semler Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Semler Scientific's price. Additionally, you may evaluate how the addition of Semler Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC